AAD

Anne Arundel Dermatology Names Vincent Bradley as Chief Executive Officer

Retrieved on: 
Wednesday, August 2, 2023
General Health, Health, Oncology, Veterinary medicine, Ridgemont Equity Partners, Dermatology, Physician, Patient, AAD, Nursing

Anne Arundel Dermatology (“AAD”), a leading provider of medical, surgical and cosmetic dermatological services, announced that Vincent Bradley has been named Chief Executive Officer.

Key Points: 
  • Anne Arundel Dermatology (“AAD”), a leading provider of medical, surgical and cosmetic dermatological services, announced that Vincent Bradley has been named Chief Executive Officer.
  • Mr. Bradley has 20 years of experience across multiple specialties within healthcare service organizations, including primary care, women’s health and veterinary medicine.
  • As an entrepreneur and business operator, he has chief executive experience leading scaled, multi-unit healthcare provider platforms through strategic growth planning and team building initiatives.
  • “I am excited to join the Anne Arundel Dermatology team and continue to build upon an exceptional track record of clinical excellence and successful collaboration with our affiliated practices,” said Mr. Bradley.

AMERICAN ACADEMY OF DERMATOLOGY: HOW TO CARE FOR AN INJURED NAIL

Retrieved on: 
Tuesday, July 25, 2023
Infection, Heart, Hair, American Academy of Dermatology, Arm, Bleeding, Accident, Nail, American Academy, Leg, Doctor of Philosophy, FAAD, Patient, AAD, Swelling, Paracetamol, Water, Weill Cornell Medicine, Ibuprofen, Bacteria, Shoe, Health, Skin, Injury, Petroleum jelly, Cosmetics

ROSEMONT, Ill., July 25, 2023 /PRNewswire/ -- It's easy to injure a nail by slamming a finger in a car door, wearing the wrong shoes, or getting a sports injury. While these common accidents can happen throughout our life, a board-certified dermatologist from the American Academy of Dermatology (AAD) is providing tips to help you treat an injured nail at home, so you're prepared if it happens.

Key Points: 
  • While these common accidents can happen throughout our life, a board-certified dermatologist from the American Academy of Dermatology (AAD) is providing tips to help you treat an injured nail at home, so you're prepared if it happens.
  • If you do get a nail injury, Dr. Lipner and the AAD recommend these tips:
    Treat your wound.
  • Prop the arm or leg with an injured nail on pillows so the nail is higher than your heart.
  • These tips are demonstrated in " How to Care for an Injured Nail ," a video posted to the AAD website and YouTube channel .

Young Pharmaceuticals Announces Exclusive Distribution Partnership with TrulyO2

Retrieved on: 
Thursday, July 20, 2023
Dermatology, Young, AAD

HARTFORD, Conn., July 20, 2023 /PRNewswire/ -- Young Pharmaceuticals, Inc., a leading provider of physician-dispensed skincare, announces an exclusive distribution agreement with Boulder-based TrulyO2, a maker of proprietary topical micro-oxygen delivery products.

Key Points: 
  • HARTFORD, Conn., July 20, 2023 /PRNewswire/ -- Young Pharmaceuticals, Inc., a leading provider of physician-dispensed skincare, announces an exclusive distribution agreement with Boulder-based TrulyO2, a maker of proprietary topical micro-oxygen delivery products.
  • "Young is proud to partner with TrulyO2 and introduce this remarkable technology to our market channel of elite plastic surgeons and dermatologists," says John Kulesza, Young Pharmaceuticals President.
  • The exclusive license includes the proprietary DeepO2 formula and will only be available under private label through Young's channel of dispensing medical offices and their online stores.
  • TrulyO2 CEO Bob Scribner says, "We are excited to join forces with Young in the world's largest dermatology and plastic surgery market.

Zambon Presents Results from the Two Phase 3 PROMIS Studies of CMS I-neb in Patients with Non-Cystic Fibrosis Bronchiectasis at World Bronchiectasis Conference 2023

Retrieved on: 
Tuesday, July 18, 2023
CMS, Registry, Bronchiectasis, QIDP, Safety, Efficacy, COVID-19, Saint George, Quality of life, Pseudomonas aeruginosa, LS, Visit, Incidence, AER, MILAN, AAD, Lower respiratory tract infection, Management, Health, FDA, Conference, Disease, Pharmaceutical industry, Poster, Patient

The trials explored the effect of CMS I-neb on the frequency of pulmonary exacerbations in NCFB patients chronically infected with P. aeruginosa.

Key Points: 
  • The trials explored the effect of CMS I-neb on the frequency of pulmonary exacerbations in NCFB patients chronically infected with P. aeruginosa.
  • A total of 377 patients were randomized, 177 to CMS I-neb and 200 to placebo.
  • "Results of PROMIS-II were unexpected in light of the positive data seen in PROMIS-I and the Phase 2 trial.
  • There are no approved inhaled treatments currently available for patients with bronchiectasis and P. aeruginosa infection.

MANA PRODUCTS ANNOUNCES THE ESTABLISHMENT OF SCIENTIFIC ADVISORY BOARD

Retrieved on: 
Wednesday, July 5, 2023
SAB, Skin, Society, SCC, Specialization, Doctor of Pharmacy, Senior, University, Society of Cosmetic Chemists, Seowon University, University of Cincinnati, California Academy of Sciences, United States Air Force Scientific Advisory Board, Doctor of Philosophy, Associate, Research and development, Maison, Development, MANA, Assistant professor, Procter & Gamble, Publication, MD, AAD, MA, Human, Conference, Disease, Pharmaceutical industry, Cosmetics, Management, Pharmacy, Rutgers University, Amway, Research

NEW YORK, July 5, 2023 /PRNewswire/ -- MANA Products, the world's leading partner for innovative development and manufacturing of branded and private label prestige beauty products, announces the establishment of a new Scientific Advisory Board (SAB).

Key Points: 
  • NEW YORK, July 5, 2023 /PRNewswire/ -- MANA Products, the world's leading partner for innovative development and manufacturing of branded and private label prestige beauty products, announces the establishment of a new Scientific Advisory Board (SAB).
  • The formation of this board of global, distinguished scientists reflects MANA's commitment to support research and development and scientific advancements in the beauty industry.
  • The board members bring scientific expertise and experience in cosmetic dermatology, biosciences, active ingredient development, topical ingredient delivery systems, and the skin microbiome and its role in skin health and wellness.
  • MANA's Scientific Advisory Board includes:
    Gopinathan Menon, PhD.

MANA PRODUCTS ANNOUNCES THE ESTABLISHMENT OF SCIENTIFIC ADVISORY BOARD

Retrieved on: 
Wednesday, July 5, 2023
SAB, Skin, Society, SCC, Specialization, Doctor of Pharmacy, Senior, University, Society of Cosmetic Chemists, Seowon University, University of Cincinnati, California Academy of Sciences, United States Air Force Scientific Advisory Board, Doctor of Philosophy, Associate, Research and development, Maison, Development, MANA, Assistant professor, Procter & Gamble, Publication, MD, AAD, MA, Human, Conference, Disease, Pharmaceutical industry, Cosmetics, Management, Pharmacy, Rutgers University, Amway, Research

NEW YORK, July 5, 2023 /PRNewswire/ -- MANA Products, the world's leading partner for innovative development and manufacturing of branded and private label prestige beauty products, announces the establishment of a new Scientific Advisory Board (SAB).

Key Points: 
  • NEW YORK, July 5, 2023 /PRNewswire/ -- MANA Products, the world's leading partner for innovative development and manufacturing of branded and private label prestige beauty products, announces the establishment of a new Scientific Advisory Board (SAB).
  • The formation of this board of global, distinguished scientists reflects MANA's commitment to support research and development and scientific advancements in the beauty industry.
  • The board members bring scientific expertise and experience in cosmetic dermatology, biosciences, active ingredient development, topical ingredient delivery systems, and the skin microbiome and its role in skin health and wellness.
  • MANA's Scientific Advisory Board includes:
    Gopinathan Menon, PhD.

AMERICAN ACADEMY OF DERMATOLOGY URGES AMERICANS TO USE SUN PROTECTION AHEAD OF JULY 4th WEEKEND

Retrieved on: 
Tuesday, June 27, 2023
Infection, Dehydration, Parent, Heat exhaustion, Skin cancer, Clothing, Blister, SPF, American Academy, Child, FAAD, Aspirin, Aloe vera, Pain, Royal National Hospital for Rheumatic Diseases, Children's National Hospital, Dermatology, Swimming, Allergy, AAD, Risk, Melanoma, Water, Benzocaine, American Academy of Dermatology, Swelling, UV, Perspiration, Ibuprofen, Sunburn, Dry, Family, Red, Skin, Petroleum jelly, Cosmetics, MD

ROSEMONT, Ill., June 27, 2023 /PRNewswire/ -- The July 4th weekend is a time when many Americans will celebrate outdoors at parades, pools and cookouts, but without proper sun protection, they put themselves and their children at risk of getting sunburned, which increases the chances of developing skin cancer.

Key Points: 
  • A recent American Academy of Dermatology survey of more than 1,000 U.S. adults revealed that one-third of American parents reported having a child who was sunburned in 2022.
  • People can avoid sunburn by seeking shade, remembering that the sun's rays are the strongest between 10 a.m. and 2 p.m., she said.
  • Additionally, people should wear a lightweight and long-sleeved shirt, pants, a wide-brimmed hat, and sunglasses with UV protection, when possible.
  • "I tell parents to make sure that their children are willing to apply sunscreen themselves," said Dr. Kirkorian.

American Academy of Dermatology launches innovative project to improve outcomes for patients with life-threatening pustular psoriasis

Retrieved on: 
Thursday, June 22, 2023
American Academy of Dermatology, OM1, Quality of life, American Academy, Privacy, Patient, Doctor of Philosophy, FAAD, Psoriasis, Boehringer Ingelheim, HIV disease progression rates, Skin, AAD, Annual general meeting, Single-use medical devices, Diagnosis, GPP, AI, Artificial intelligence, Health, Disease, Medical device, Nursing, Pharmaceutical industry, Dermatology

The AAD's new Generalized Pustular Psoriasis Education Initiative aims to transform the care of these patients by leveraging the power of data in the Academy's DataDerm™ dermatology patient registry.

Key Points: 
  • The AAD's new Generalized Pustular Psoriasis Education Initiative aims to transform the care of these patients by leveraging the power of data in the Academy's DataDerm™ dermatology patient registry.
  • The project will connect DataDerm's 50 million deidentified patient encounters with OM1's AI-based Patient Finder™ tool to improve understanding of GPP patients' journey, treatment patterns, disease progression, and outcomes.
  • "The American Academy of Dermatology is committed to excellence in dermatology and finding innovative approaches to improve patient care," said AAD President Terrence A. Cronin Jr., MD., FAAD.
  • Findings from the first phase of the project will be shared at the American Academy of Dermatology's 2024 Annual Meeting, March 8 – 12 in San Diego.

Mary Kay Inc. Presents New Findings on Three Botanical Extracts That Can Reduce the Appearance of Facial Expression Lines

Retrieved on: 
Tuesday, June 20, 2023
Lifestyle, Alternative Medicine, Other Health, Health, Women, Cosmetics, Research, Retail, Fitness & Nutrition, Consumer, Science, Skin care, Contract management, B cell, American Academy, Multimedia, Associate, AAD, Mary Kay, Annual general meeting, Human, Forehead, Skin, Management, Pharmaceutical industry

Mary Kay Inc., a global leader in skin care innovation and nutritional science, recently revealed breakthrough research on a treatment that combats the appearance of facial expression lines.

Key Points: 
  • Mary Kay Inc., a global leader in skin care innovation and nutritional science, recently revealed breakthrough research on a treatment that combats the appearance of facial expression lines.
  • View the full release here: https://www.businesswire.com/news/home/20230620260890/en/
    Dr. Lucy Gildea, Chief Innovation Officer, Product & Science at Mary Kay and her team recently revealed new findings on extracts that can reduce the appearance of facial expression lines.
  • (Photo: Mary Kay Inc.)
    “Women are looking for holistic alternatives to invasive, often expensive in-office procedures to address facial expression lines,” said Dr. Lucy Gildea, Chief Innovation Officer, Product & Science at Mary Kay.
  • Mary Kay holds more than 1,600 patents for products, technologies and packaging designs in its global portfolio.

ACELYRIN, INC. Reports First Quarter 2023 Financial Results and Recent Highlights

Retrieved on: 
Thursday, June 15, 2023
Acceleration, Exercise, TED, SLRN, IPO, POC, IPR, D, Abscess, Enthesitis, Public, Quality of life, American Academy, Research, Doctor of Philosophy, Connective tissue, Graves' ophthalmopathy, Hidradenitis suppurativa, Psoriatic arthritis, Acquisition, MD, AAD, Patient, American Academy of Dermatology, LOS, Data monitoring committee, Hives, Neuro-ophthalmology, III, DMC, Disease, Autoimmunity, Inflammation, Life insurance, Pharmaceutical industry, HS

With the proceeds of our recent initial public offering, we will continue to drive towards key value-driving milestones to deliver efficiently on our development plans.

Key Points: 
  • With the proceeds of our recent initial public offering, we will continue to drive towards key value-driving milestones to deliver efficiently on our development plans.
  • Part B of the Phase 2b/3 trial completed enrollment early and top-line results are now anticipated in Q3 2023.
  • Net Loss: Net loss totaled $176.5 million for the first quarter of 2023, compared to $16.1 million for the first quarter of 2022.
  • This includes the one-time $123.1 million IPR&D charge and $10.0 million license payment, both related to the acquisition of ValenzaBio.